Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8641-8650 Newer>

Chemistry World July 31, 2013 Daniel Johnson	Perrigo bags Elan and its bargain Irish tax rates US drugmaker Perrigo has agreed to buy Irish pharma company Elan in a deal worth $8.6 billion. This hands Perrigo a base in low-tax Ireland and annual savings of up to $150 million in tax and operating costs.
Chemistry World July 31, 2013 Andy Extance	Pfizer reshuffle hints at future split decision Pharmaceutical giant Pfizer is internally dividing its commercial operations into three business segments, which will report profits separately from 2014 onwards.
Chemistry World July 31, 2013 Daniel Johnson	Animal testing failures put drug trial volunteers in danger The reporting of animal studies is biased, inflating the efficacy of drug candidates and pushing them into the clinic before they are ready.
Chemistry World July 30, 2013 Emma Stoye	Thousands face job cuts after Valeant's Bausch buyout Canadian pharmaceutical company Valeant plans to lay off up to 2700 staff to help finance its $8.7 billion acquisition of US eye health specialist Bausch & Lomb.
Chemistry World July 30, 2013	Animal pharm Making drugs to treat animals is a potentially lucrative market -- but the path to success is a difficult one, as Clare Sansom discovers
Chemistry World July 29, 2013 Hepeng Jia	China corruption investigation broadens Investigations of corrupt practices at GlaxoSmithKline in China are continuing. But analysts claim that the scandal is an attempt to remodel the Chinese drugs market, rather than a deliberate attack on international companies.
Pharmaceutical Executive July 1, 2013 Wernli & Ganor	Dangerous Liaisons: Terrorism and Pharma How vulnerable is Big Pharma to the predations of organized terrorist groups or that rogue malcontent with an agenda to wreak havoc on society?
Pharmaceutical Executive July 1, 2013 Looney et al.	Pharm Exec's 2013 Emerging Pharma Leaders Meet the Emerging Pharma Leaders of 2013. These 15 trend setters represent the future of an industry that knows it must change: the question is how, and to what?
Pharmaceutical Executive July 1, 2013	Country Report: Colombia Colombia is focusing on bolstering the commercial sector. While this is good news for the pharmaceutical industry, there is still a strong debate about how healthcare in Colombia can be improved.
Pharmaceutical Executive July 1, 2013 Ben Comer	What is a Journal Reprint Worth? Pharma and physicians worry about getting sunburned by the Sunshine Act.
<Older 8641-8650 Newer> Return to current articles.